ABEO
Abeona Therapeutics Inc
5.00$
-2.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -174.2% | -1,002.2% | -1,463.9% | -2,740.1% | -1,304.6% | – | -350.2% | -2,188.8% | -3,075.2% | -1,057.4% | – | -1,311.4% | |
| 1.2% | 53.0% | 92.8% | 88.5% | 78.7% | – | 56.0% | 148.8% | 323.7% | 91.4% | – | 61.2% | |
| 141.1% | 420.0% | 543.2% | 706.8% | 295.7% | – | 81.9% | 297.2% | 215.8% | 136.2% | – | 185.2% | |
| 2,677.2% | 458.6% | 543.2% | 539.7% | 251.9% | – | 419.8% | 1,102.3% | – | – | – | – | |
| 42.4% | -583.6% | -25.5% | -256.4% | 232.2% | – | 16.3% | -608.8% | -416.7% | -51.1% | – | -92.6% | |
| 33.3% | 29.6% | 58.4% | 102.7% | 650.2% | – | 13.4% | 138.4% | 9.2% | 9.5% | – | 137.0% | |
| 366.4% | 325.9% | -58.4% | -102.7% | -2,838.1% | – | -837.1% | 2,202.1% | -1,694.8% | 5.9% | – | 1,804.6% | |
| 1,251,783.8% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 1,330.5% | 1,118.8% | 4,784.8% | 11,039.8% | 182.7% | – | 1.8% | 0.0% | -1,856.4% | -5.2% | – | – | |
| 43.2% | -38.5% | – | 210.0% | 58.6% | – | 17.6% | 0.0% | – | 0.0% | – | 0.0% | |
| 1,373.7% | 3,428.1% | 4,784.8% | 11,039.8% | 182.7% | – | 19.4% | 828.7% | 3,053.3% | 1,058.8% | – | 447.4% | |
| 1,199.6% | 2,751.7% | 3,262.5% | 8,196.9% | -3,960.0% | – | -1,168.0% | 841.9% | -1,716.7% | 7.3% | – | 940.6% | |
| -174.2% | -1,031.8% | -1,522.3% | -2,842.9% | -1,954.8% | – | -363.6% | -2,327.2% | -3,084.4% | -1,066.9% | – | -1,448.5% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.